Biogen’s blockbuster Tysabri loses a key patent in Europe, adding to company’s worries: analystnews2021-07-15T14:43:35+00:00July 15th, 2021|Fierce Pharma|
FDA reprimands Amgen for ‘misleading’ Neulasta claims in banner ads aimed at doctorsnews2021-07-15T14:30:45+00:00July 15th, 2021|Fierce Pharma|
After 10,000% price hike, pharma companies face $350M-plus fine in U.K.news2021-07-15T13:47:40+00:00July 15th, 2021|Fierce Pharma|
Johnson & Johnson yanks Neutrogena and Aveeno spray sunscreens on carcinogen fearsnews2021-07-15T13:23:23+00:00July 15th, 2021|Fierce Pharma|
The way it grows: CMI Media Group and Compas tap new leadership to build on gainsnews2021-07-15T03:01:19+00:00July 15th, 2021|Fierce Pharma|
Sprout’s female libido drug Addyi back in FDA’s crosshairs years after controversial approvalnews2021-07-14T15:34:38+00:00July 14th, 2021|Fierce Pharma|
Vectura’s $1.45B sale to tobacco giant Philip Morris under fire from British business secretary: reportnews2021-07-14T15:30:26+00:00July 14th, 2021|Fierce Pharma|
Merck looks to overturn FDA’s Keytruda rebuff with updated triple-negative breast cancer datanews2021-07-14T14:35:35+00:00July 14th, 2021|Fierce Pharma|
Sanofi, tightening its belt in consumer healthcare, offloads more brands to Brazil’s Hypera for $190Mnews2021-07-14T14:20:34+00:00July 14th, 2021|Fierce Pharma|
Klick Health video riffs on a Beatles song to encourage people to ‘Get Vaxxed’news2021-07-14T13:57:00+00:00July 14th, 2021|Fierce Pharma|
